Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes

Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes

Bibliographic Details
Main Authors:	Zaid H. Abdel-Rahman, Michael G. Heckman, Theodora Anagnostou, Launia J. White, Sara M. Kloft‐Nelson, Ryan A. Knudson, Hassan B. Alkhateeb, Lisa Z. Sproat, Nandita Khera, Hemant S. Murthy, Ernesto Ayala, William J. Hogan, Vivek Roy, Jess F. Peterson, Mohamed A. Kharfan-Dabaja, Rhett P. Ketterling, Mark R. Litzow, Linda B. Baughn, Mrinal Patnaik, Patricia T. Greipp, James M. Foran
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-09-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-021-00538-9

Similar Items

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
by: Anagnostou T, et al.
Published: (2017-12-01)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
by: Anagnostou T, et al.
Published: (2018-04-01)

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
by: Maansi Joshi, et al.
Published: (2021-03-01)

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
by: Ricardo D. Parrondo, et al.
Published: (2022-06-01)

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs
by: Ahmad Ghorab, et al.
Published: (2022-06-01)

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
by: Hassan B. Alkhateeb, et al.
Published: (2022-07-01)

MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma
by: Marie-France Gagnon, et al.
Published: (2021-11-01)

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
by: Mostafa Abdallah, et al.
Published: (2023-03-01)

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
by: Rami Basmaci, et al.
Published: (2023-08-01)

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE
by: Bahga Katamesh, et al.
Published: (2023-08-01)

P1323: PREDICTION OF NON-RELAPSE MORTALITY BY EASIX AND HCT-CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT
by: A. Baranwal, et al.
Published: (2022-06-01)

Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases
by: Maymona G. Abdelmagid, et al.
Published: (2022-07-01)

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
by: Muhamad Oum, et al.
Published: (2023-08-01)

CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
by: Razan Mohty, et al.
Published: (2022-12-01)

S263: CYTOPENIAS, AGE AND CAR-HEMATOTOX SCORE PREDICT THE DEVELOPMENT OF POST CAR T-CELL THERAPY-RELATED MYELOID NEOPLASMS
by: Mark Gurney, et al.
Published: (2023-08-01)

Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events
by: Maymona G. Abdelmagid, et al.
Published: (2023-08-01)

Philadelphia /
by: 340268 Davis, Christopher, et al.
Published: (1994)

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
by: Aref Al-Kali, et al.
Published: (2023-04-01)

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE
by: Amrutha Sai Mittapalli, et al.
Published: (2023-08-01)

Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia
by: Beth A. Pitel, et al.
Published: (2023-09-01)

Axicabtagene Ciloleucel in the Management of Follicular Lymphoma: Current Perspectives on Clinical Utility, Patient Selection and Reported Outcomes
by: Mohty R, et al.
Published: (2023-04-01)

Recent advances in immunotherapy for B-cell non-Hodgkin lymphoma and multiple myeloma
by: Julio C. Chavez, et al.
Published: (2022-09-01)

Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
by: Ahmad Nanaa, et al.
Published: (2021-06-01)

PHILADELPHIA CHROMOSOME
by: Habibullah Khan
Published: (2017-08-01)

Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant
by: Ayalew Tefferi, et al.
Published: (2024-03-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies
by: Mohamed A. Kharfan-Dabaja, et al.
Published: (2019-03-01)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
by: Hind Rafei, et al.
Published: (2017-10-01)

Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis
by: Marie-France Gagnon, et al.
Published: (2023-12-01)

A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients
by: Steven C. Ames, et al.
Published: (2024-02-01)

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms
by: Mithun Vinod Shah, et al.
Published: (2022-07-01)

Philadelphia : the unexpected city /
by: 384484 Lafore, Laurence Davis, et al.
Published: (1965)

The Philadelphia chromosome in leukemogenesis
by: Zhi-Jie Kang, et al.
Published: (2016-05-01)

CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
by: Julio C. Chavez, et al.
Published: (2019-04-01)

Cytokine Release Syndrome: Current Perspectives
by: Murthy H, et al.
Published: (2019-10-01)

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response
by: K. H. Begna, et al.
Published: (2022-01-01)

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study
by: Zhuoer Xie, et al.
Published: (2021-03-01)

Unemployment claims in Philadelphia one year after implementation of the sweetened beverage tax.
by: Hannah G Lawman, et al.
Published: (2019-01-01)

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity
by: Talha Badar, et al.
Published: (2023-09-01)

Loneliness, immunological recovery patterns, and health-related quality of life (HRQOL) outcomes in patients receiving hematopoietic stem cell transplantation
by: Lori J. Lange, et al.
Published: (2024-01-01)